Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells

Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells

Abstract Background Hepatocellular carcinoma (HCC) is one of the most common malignancies, with an increasing incidence. Despite the fact that systematic chemotherapy with a doxorubicin provides only marginal improvements in survival of the HCC patients, the doxorubicin is being used in transarteria...

Full description

Bibliographic Details
Main Authors: Agnieszka Korga, Marta Ostrowska, Aleksandra Jozefczyk, Magdalena Iwan, Rafal Wojcik, Grazyna Zgorka, Mariola Herbet, Gemma Gomez Vilarrubla, Jaroslaw Dudka
Format: Article
Language:English
Published: BMC 2019-05-01
Series:BMC Pharmacology and Toxicology
Subjects:
Doxorubicin
Apigenin
Hesperidin
Flavonoids
Hepatocellular carcinoma
Online Access:http://link.springer.com/article/10.1186/s40360-019-0301-2

Internet

http://link.springer.com/article/10.1186/s40360-019-0301-2

Similar Items